University of Colorado Anschutz

Running trials

• Not yet recruiting

  A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis

  NCT07335562· Phase 3· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Source

• Not yet recruiting

  Testing Heart Failure Resilience Intervention for Caregivers (HEROIC) in Advanced Heart Failure

  NCT07805811· Phase 2· Johns Hopkins University· Source

• Not yet recruiting

  Digitally Enhanced Cognitive-Behavioral Therapy

  NCT07569991· Colorado State University· Source

• Not yet recruiting

  A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma

  NCT07728188· Phase 3· AbbVie· Source

• Not yet recruiting

  A Study of LY3873862 in Participants With Sporadic or Familial Amyotrophic Lateral Sclerosis (ALS).

  NCT07883590· Phase 1· Eli Lilly and Company· Source

• Recruiting

  Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)

  NCT07665372· Johns Hopkins University· Source

• Recruiting

  A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

  NCT07881458· Phase 3· Eli Lilly and Company· Source

• Not yet recruiting

  Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis

  NCT07520110· Phase 3· University of Massachusetts, Worcester· Source

• Recruiting

  Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.

  NCT07465718· Phase 3· Orphalan· Source

• Not yet recruiting

  Single Arm Intervention Trial of DEKA TWIIST TM Insulin Pump Utilizing Tidepool Loop Algorithm in Pregnant People With Pre-existing Type 1 Diabetes

  NCT07808385· Mayo Clinic· Source

• Not yet recruiting

  Targeting Immune Modulation in High Grade Serous Carcinoma: Combined Effects of Chemotherapy and Atorvastatin

  NCT07815704· Phase 2· University of Colorado, Denver· Source

• Recruiting

  An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

  NCT06996652· Phase 2· Yale University· Source

• Not yet recruiting

  Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity

  NCT07021937· Phase 3· University of Colorado, Denver· Source

• Recruiting

  Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-Being

  NCT07628647· University of Colorado, Denver· Source

• Recruiting

  Multi-Site Trial of Tirzepatide for Smoking Cessation

  NCT07602699· Phase 2· University of Southern California· Source

• Recruiting

  The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer

  NCT07636200· University of Colorado, Boulder· Source

• Recruiting

  Collaboration for Down Syndrome Progress (CDP)

  NCT07625579· RTI International· Source

• Recruiting

  An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

  NCT07365332· Phase 3· Inhibikase Therapeutics· Source

• Enrolling by invitation

  Epidural Stimulation to Restore Voluntary Movement Following Spinal Cord Injury

  NCT05966896· University of Colorado, Denver· Source

• Recruiting

  A Gaucher Disease Gene Therapy Trial With FLT201

  NCT07223944· Phase 3· Spur Therapeutics· Source

• Recruiting

  The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms

  NCT07143019· phenox Inc.· Source

• Recruiting

  Snacking Effects on the Brain Response to Foods and Satiety During Dieting

  NCT07428187· University of Colorado, Denver· Source

• Recruiting

  TOUCH® CMC 1 New Enrollment US Study

  NCT07405983· Keri Medical SA· Source

• Recruiting

  REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool

  NCT07280065· Phase 3· Senseye, Inc.· Source

• Recruiting

  Equol and Vascular Function in Women With Chronic Kidney Disease

  NCT07194590· Phase 2· University of Colorado, Denver· Source

• Recruiting

  Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

  NCT07011147· University of Colorado, Denver· Source

• Recruiting

  A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta

  NCT07078383· Vascutek Ltd.· Source

• Not yet recruiting

  Development And Evaluation of An Adaptive Web-Based Intervention for COPD

  NCT06770777· University of Colorado, Denver· Source

• Recruiting

  Colorado Community Engagement Alliance

  NCT07440316· University of Colorado, Denver· Source

• Recruiting

  A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

  NCT07165028· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  Forward to Quit: A Person-centered Mobile Technology Intervention for Smoking Cessation Among Transgender Adults

  NCT07181551· University of Colorado, Denver· Source

• Recruiting

  Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors

  NCT07001241· Phase 2· University of Colorado, Denver· Source

• Recruiting

  A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

  NCT06624644· Phase 2/3· Linnaeus Therapeutics, Inc.· Source

• Recruiting

  NightWare and Cardiovascular Health in Women With PTSD

  NCT07021014· University of Colorado, Denver· Source

• Recruiting

  Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease

  NCT07576894· University of Colorado, Denver· Source

• Recruiting

  Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

  NCT06909565· Phase 4· Duke University· Source

• Recruiting

  Evaluating Changes in Synovial Fluid Before and After GAE for Knee Osteoarthritis

  NCT06940479· University of Colorado, Denver· Source

• Recruiting

  Spanish-language Executive Function Intervention for Children With Autism and/or ADHD

  NCT07084324· University of Colorado, Denver· Source

• Active, not recruiting

  A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

  NCT07015983· Phase 2· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Source

• Recruiting

  Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV

  NCT06554717· Phase 2· Massachusetts General Hospital· Source

• Recruiting

  Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

  NCT06972056· Phase 4· Mayo Clinic· Source

• Not yet recruiting

  Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY)

  NCT06973629· Phase 3· Brainstorm-Cell Therapeutics· Source

• Recruiting

  Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

  NCT06808984· Phase 2· Celgene· Source

• Recruiting

  Project Safe Guard-Trauma

  NCT06876740· University of Colorado, Denver· Source

• Recruiting

  Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  NCT06563895· Phase 3· Eidos Therapeutics, a BridgeBio company· Source

• Active, not recruiting

  A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight

  NCT06962280· Phase 3· Eli Lilly and Company· Source

• Recruiting

  PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

  NCT06855329· University of Massachusetts, Worcester· Source

• Active, not recruiting

  A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

  NCT06914895· Phase 3· Eli Lilly and Company· Source

• Recruiting

  An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

  NCT06951217· Phase 2· Avalyn Pharma Inc.· Source

• Active, not recruiting

  A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment

  NCT06848088· Phase 2· Regeneron Pharmaceuticals· Source

Showing 50 of 182.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity13 recruiting
• High blood pressure6 recruiting
• Chronic kidney disease5 recruiting
• Colorectal cancer5 recruiting
• Idiopathic pulmonary fibrosis5 recruiting
• Lung cancer5 recruiting
• Melanoma5 recruiting
• Parkinson disease5 recruiting
• Type 1 diabetes5 recruiting
• Metastatic breast cancer4 recruiting
• Ovarian cancer4 recruiting
• Prostate cancer4 recruiting
• Pulmonary arterial hypertension4 recruiting
• Type 2 diabetes4 recruiting
• ALS (motor neurone disease)3 recruiting
• Alzheimer disease3 recruiting
• Autism3 recruiting
• COPD3 recruiting
• Heart failure3 recruiting
• Liver and biliary tract cancer3 recruiting
• Pancreatic cancer3 recruiting
• Aortic aneurysm2 recruiting
• Barrett's oesophagus2 recruiting
• Epilepsy2 recruiting
• Gastric and oesophageal cancer2 recruiting
• Glioblastoma2 recruiting
• HIV2 recruiting
• Kidney cancer2 recruiting
• Multiple sclerosis2 recruiting
• Osteoarthritis2 recruiting
• Acute myeloid leukaemia1 recruiting
• Amyloidosis1 recruiting
• Asthma1 recruiting
• Bladder cancer1 recruiting
• Brain aneurysm1 recruiting
• Cervical cancer1 recruiting
• Coronary artery disease1 recruiting
• Crohn's disease1 recruiting
• Depression1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Down syndrome1 recruiting
• Familial hypercholesterolaemia1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Female infertility1 recruiting
• Follicular lymphoma1 recruiting
• Gaucher disease1 recruiting
• Glaucoma1 recruiting
• Head and neck cancer1 recruiting
• Hearing loss1 recruiting
• Lupus (SLE)1 recruiting
• Mesothelioma1 recruiting
• Migraine1 recruiting
• Mild cognitive impairment1 recruiting
• Multiple myeloma1 recruiting
• Myasthenia gravis1 recruiting
• Myelodysplastic syndromes1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Nephrotic syndrome1 recruiting
• Osteoporosis1 recruiting
• Polycystic kidney disease1 recruiting
• Rheumatoid arthritis1 recruiting
• Schizophrenia1 recruiting
• Spinal cord injury1 recruiting
• Stroke1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting
• Triple-negative breast cancer1 recruiting
• Wilson disease1 recruiting

Closed trials

• Completed

  Adapting rHIRE and Sleep Monitoring in Parkinson's Disease

  NCT07498296· University of Colorado, Denver· Source

• Completed

  Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D

  NCT07005362· University of Colorado, Denver· Source

• Completed

  Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes

  NCT06535789· Phase 2/3· Jaeb Center for Health Research· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis.

  NCT06899217· Phase 2· CinDome Pharma, Inc.· Source

• Terminated

  Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1

  NCT06714591· Phase 1· SystImmune Inc.· Source

• Completed

  A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity

  NCT06717425· Phase 2· Pfizer· Source

• Completed

  RECOVER-SLEEP: Platform Protocol

  NCT06404086· Phase 2· Duke University· Source

• Completed

  Psilocybin for Treatment-Resistant Depression

  NCT06230757· Phase 2· University of Colorado, Denver· Source

• Completed

  Prevention and Choice for Type 2

  NCT06377020· University of Colorado, Denver· Source

• Completed

  Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)

  NCT05892432· Phase 2· University of Colorado, Denver· Source

• Completed

  A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population

  NCT06052319· Janssen Scientific Affairs, LLC· Source

• Withdrawn

  Trial to Evaluate Safety and Efficacy of GM-CSF /Sargramostim in Down Syndrome

  NCT05482334· Phase 2· University of Colorado, Denver· Source

• Completed

  RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Long COVID Symptoms

  NCT05965752· Duke University· Source

• Terminated

  CD40L Antagonism in Rheumatoid Arthritis (RA)

  NCT05306353· Phase 2· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Completed

  A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

  NCT05936151· Phase 2· Eli Lilly and Company· Source

• Completed

  A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

  NCT05929066· Phase 3· Eli Lilly and Company· Source

• Completed

  Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis

  NCT05671835· Phase 2· Tvardi Therapeutics, Incorporated· Source

• Completed

  A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk

  NCT05803421· Phase 3· Eli Lilly and Company· Source

• Completed

  Colorado Oral Strengthening Device

  NCT05464225· University of Colorado, Denver· Source

• Completed

  Assessing Speech Perception and Amplification Benefit During Infancy

  NCT05653999· University of Colorado, Denver· Source

• Completed

  Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults with PTSD

  NCT05717439· Senseye, Inc.· Source

• Recruiting

  A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

  NCT05667142· Phase 3· Xenon Pharmaceuticals Inc.· Source

• Completed

  A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

  NCT05536804· Phase 2· Eli Lilly and Company· Source

• Completed

  A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)

  NCT05662332· Phase 3· Eli Lilly and Company· Source

• Completed

  A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

  NCT05463744· Phase 3· Eli Lilly and Company· Source

• Completed

  NightWare and Cardiovascular Health in Adults With PTSD

  NCT05365607· University of Colorado, Denver· Source

• Completed

  Implementing Continuous Glucose Monitoring in Primary Care for Patients With Diabetes

  NCT05336214· University of Colorado, Denver· Source

• Terminated

  A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

  NCT05310071· Phase 3· Biogen· Source

• Completed

  The Effect of Acute Intermittent Hypoxia on Motor Learning

  NCT05341466· University of Colorado, Boulder· Source

• Completed

  "Safety in Dementia": An Online Caregiver Intervention

  NCT05173922· University of Colorado, Denver· Source

• Terminated

  A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE

  NCT05171049· Phase 3· Anthos Therapeutics, Inc.· Source

• Completed

  Naturalistic Sleep Assessed by Wearable Devices in Parkinson Disease

  NCT05348837· University of Colorado, Denver· Source

• Completed

  Defining Endpoints in Becker Muscular Dystrophy

  NCT05257473· Virginia Commonwealth University· Source

• Completed

  Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor

  NCT05216250· Phase 2· AbbVie· Source

• Completed

  Effects of DHEA and Exercise on Bone Marrow Fat in Postmenopausal Women

  NCT05316272· University of Colorado, Denver· Source

• Completed

  Reducing Pain and Opioid Use With CBD

  NCT05299944· Phase 2· University of Colorado, Denver· Source

• Terminated

  A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)

  NCT05121948· Phase 1· HiberCell, Inc.· Source

• Withdrawn

  Inhaled NAC in Treatment of IPF

  NCT03720483· Phase 1/2· University of Colorado, Denver· Source

• Completed

  Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)

  NCT04979130· Phase 4· University of Colorado, Denver· Source

• Completed

  An Open-Label Study Following Oral Dosing of Seladelpar to Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

  NCT04950764· Phase 1· Gilead Sciences· Source

• Completed

  Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity

  NCT05107908· University of Colorado, Denver· Source

• Terminated

  A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

  NCT05085366· Phase 3· ModernaTX, Inc.· Source

• Completed

  COMT Inhibition Among Individuals With Comorbid AUD/ADHD

  NCT03904498· Phase 2· University of Colorado, Denver· Source

• Completed

  Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

  NCT04971785· Phase 2· Gilead Sciences· Source

• Completed

  Efficacy and Safety of Pembrolizumab Plus Investigational Agents in Combination With Chemotherapy as First-Line Treatment in Extensive-Stage Small Cell Lung Cancer (ES-SCLC) (MK-3475-B99/ KEYNOTE-B99)

  NCT04924101· Phase 2· Merck Sharp & Dohme LLC· Source

• Completed

  Sex Hormone and Vascular Function in Women With CKD

  NCT05471518· University of Colorado, Denver· Source

• Completed

  Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1

  NCT04886518· Phase 2· Harmony Biosciences Management, Inc.· Source

• Completed

  Myocardial Injury and Dysfunction Associated With COVID-19 Vaccination

  NCT05359250· University of Colorado, Denver· Source

• Completed

  High-Intensity Exercise to Attenuate Limitations and Train Habits in Older Adults With HIV

  NCT04550676· University of Colorado, Denver· Source

• Completed

  CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC

  NCT04681131· Phase 2· BioAtla, Inc.· Source

Showing 50 of 67.

Conditions

Diseases this institution publishes on or runs trials for.

• Obesity229 works · 32 trials
• Heart failure178 works · 5 trials
• HIV166 works · 3 trials
• Stroke145 works · 2 trials
• Type 2 diabetes132 works · 17 trials
• Type 1 diabetes123 works · 11 trials
• Lung cancer105 works · 11 trials
• Asthma97 works · 1 trial
• Alzheimer disease92 works · 5 trials
• Chronic kidney disease82 works · 12 trials
• Cystic fibrosis78 works · 0 trials
• Melanoma77 works · 7 trials
• Down syndrome75 works · 2 trials
• Epilepsy71 works · 5 trials
• Multiple sclerosis56 works · 11 trials
• Parkinson disease50 works · 9 trials
• Sarcoma47 works · 0 trials
• Acute myeloid leukaemia43 works · 2 trials
• Hearing loss43 works · 2 trials
• Tuberculosis43 works · 0 trials
• Congenital heart disease36 works · 0 trials
• Pulmonary arterial hypertension36 works · 6 trials
• Rheumatoid arthritis35 works · 3 trials
• COPD35 works · 3 trials
• Osteoarthritis34 works · 3 trials
• Idiopathic pulmonary fibrosis34 works · 8 trials
• Childhood cancers33 works · 0 trials
• Deep vein thrombosis and pulmonary embolism33 works · 3 trials
• Glioblastoma30 works · 3 trials
• Ovarian cancer30 works · 4 trials